Skip to content

Clinical trials

Phase 4 Hypertension trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypertension Phase: Phase 4 Country / region: China Clear all

74 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20031
20041
20051
20061
20072
20087
20092
20104
20115
20121
20132
20144
20154
20162
20172
20184
20192
20203
20218
20221
20234
20247
20251
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed35
Unknown status23
Recruiting7
Not yet recruiting4
Active, not recruiting2
Terminated1
Enrolling by invitation1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Shanghai Jiao Tong University School of Medicine9
Shenzhen Ausa Pharmed Co.,Ltd5
Sanofi4
Jing Liu3
Third Military Medical University3
Bayer2
China National Center for Cardiovascular Diseases2
Chinese Academy of Medical Sciences, Fuwai Hospital2
Jun Tao2
Lee's Pharmaceutical Limited2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypertension74
Essential Hypertension4
Stroke4
Atrial Fibrillation3
Cardiovascular Diseases3
Dyslipidemias3
Hyperaldosteronism3
Hypertrophy, Left Ventricular3
Obesity3
Obesity, Abdominal3

Trials

Showing 1 to 25 of 74. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.